Bell & Brown Wealth Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Bell & Brown Wealth Advisors's DGX Position: Q1 2024 in Review
Bell & Brown Wealth Advisors sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 1,665 shares — an estimated $230K sold.
Bell & Brown Wealth Advisors first reported a position in DGX in Q4 2017 and held it in 21 quarters. The position peaked at $349K in Q3 2021. 819 funds tracked by Wall St. Rank hold DGX as of Q1 2024.
- Bell & Brown Wealth Advisors reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
- Bell & Brown Wealth Advisors sold 1,665 Quest Diagnostics shares in Q1 2024, an estimated $230K.
- Bell & Brown Wealth Advisors first reported a position in Quest Diagnostics in Q4 2017 and held it in 21 quarters.
- Bell & Brown Wealth Advisors's Quest Diagnostics position peaked at $349K in Q3 2021.
- 819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.
Based on Bell & Brown Wealth Advisors's 13F filing for Q1 2024, filed 13 May 2024.